Aquamarine is a new 5%+ passive holder. Monitor for any future conversion to 13D (activist intent) or further stake changes. The passive certification limits near-term activist risk.
Price Chart
How similar events traded
Executive Summary
Aquamarine Financial (Cayman) Ltd filed an amended Schedule 13G disclosing a 6.38% passive stake in Oramed Pharmaceuticals as of September 30, 2026, representing 2,653,567 shares. This is a new filing by this investor; no prior stake was disclosed by Aquamarine in the cross-filing context, so this is an initial entry above the 5% threshold.
Key Financial Metrics
Key Facts
- Aquamarine Financial (Cayman) Ltd reported beneficial ownership of 2,653,567 shares of Oramed Pharmaceuticals common stock.
- The stake represents 6.38% of shares outstanding as of September 30, 2026.
- The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
- No prior filings by Aquamarine appear in the cross-filing context; this is the first disclosure above 5% by this entity.
Financial Impact
6.38% stake valued at approximately $11M based on $172M market cap
Risk Factors
- Passive holder could later convert to activist (13D) or reduce stake below 5%.
- No financial data or business updates in this filing; limited read-through for fundamentals.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001493152-26-051853 |
| Document: 0001493152-26-051853-index.html | 0001493152-26-051853 |
| Document: 0001493152-26-051853.txt | 0001493152-26-051853 |
Track record
4 reports on ORMP
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $4.03 Now $3.90 −3.23% settles Dec 15
- Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $4.55 to $4.11 Now $3.90 −14.29% ▼ −9.67% −7.20% vs SPY
- Jul 2, 202619w ago Insider Cluster Neutral 4/10 Entry $4.60 to $4.12 Now $3.90 −15.22% ▼ −10.43% −10.02% vs SPY
- Jun 30, 202619w ago 8-K Mixed 5/10 Entry $4.61 to $3.97 Now $3.90 −15.40% ▼ −13.88% −11.70% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers